ESLA
Estrella Immunopharma
$0.78
−$0.00 (−0.64%)Jul 27, 2026
Key metrics
The numbers that frame ESLA today
- Market cap
- $33.35M
- P/E (TTM)
- -2.5
- EV / FCF
- -3.9
- ROIC
- 140.1%
- Div yield
- 0%
- 52wk Low
- $0.73
- 52wk High
- $3.15
Growth
Revenue and earnings trend for ESLA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ESLA
Is Estrella Immunopharma a good buy?
No. Estrella Immunopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Estrella Immunopharma is selling at a very high price.
What is the market capitalization of ESLA?
Estrella Immunopharma's market capitalization is $33.35M.
What is the P/E ratio for ESLA stock?
Estrella Immunopharma's current P/E ratio is -2.5.
What is the 52-week high for ESLA stock?
The 52-week high for Estrella Immunopharma is $3.15. The current close of $0.78 is 75.4% below that high.
What is the 52-week low for ESLA stock?
The 52-week low for Estrella Immunopharma is $0.73. The current close of $0.78 is 6.2% above that low.
Does ESLA stock pay dividends?
Estrella Immunopharma does not currently show a dividend per share in the company data.